Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$2.4 - $3.64 $2,400 - $3,640
-1,000 Reduced 33.33%
2,000 $6,000
Q2 2022

Aug 10, 2022

SELL
$2.35 - $4.47 $235 - $447
-100 Reduced 3.23%
3,000 $11,000
Q1 2022

May 04, 2022

SELL
$3.5 - $5.16 $3,850 - $5,676
-1,100 Reduced 26.19%
3,100 $12,000
Q3 2021

Nov 05, 2021

BUY
$6.2 - $8.34 $19,840 - $26,688
3,200 Added 320.0%
4,200 $28,000
Q1 2021

May 13, 2021

BUY
$5.32 - $8.96 $5,320 - $8,960
1,000 New
1,000 $8,000

Others Institutions Holding ACIU

About AC Immune SA


  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $296M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.